Trials / Withdrawn
WithdrawnNCT05105490
Post Market Observational Trial for the PerQdisc Nucleus Replacement Device
PerQdisc PMCF1 Observational Trial to Evaluate the Clinical Performance and Safety of the PerQdisc Nucleus Replacement Device
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Spinal Stabilization Technologies · Industry
- Sex
- All
- Age
- 21 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
PerQdisc PMCF1 is a post-market clinical follow-up observational trial to follow subjects receiving a PerQdisc spinal implant for a duration of 5 years.
Detailed description
This study will be a prospective, open-label, multi-center post-market observational study including 72 patients that will collect additional safety and efficacy data for the Spinal Stabilization Technologies PerQdisc Nucleus Replacement System. Primary endpoints will be used to assess the safety and efficacy of the PerQdisc device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PerQdisc | Observational trial to collect post-market safety and efficacy information in a limited number of human patients |
Timeline
- Start date
- 2021-12-31
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2021-11-03
- Last updated
- 2025-05-21
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05105490. Inclusion in this directory is not an endorsement.